Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

Months after posting weight loss of 7.5% at 36 days for patients taking MET-097i, Metsera releases mid-stage results of just ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

CytomX’s workforce cuts could leave the biotech with fewer than 75 employees as it focuses resources on its wholly owned ...

Amid recent backlash stemming from market withdrawals and trial delays, the FDA seeks to further clarify its requirements for ...

Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and ...

The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, ...